Gerald Minuk

Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

Thierry Poynard, Patrick Marcellin, Samuel S. Lee et al. · The Lancet · 1998 · 2.3K citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Fatty Infiltration of Liver in Hyperlipidemic Patients

Nimer Assy, Kelly Kaita, David Mymin et al. · Digestive Diseases and Sciences · 2000 · 364 citations

Medicine, Internal Medicine, Pathology +13

Efficacy and Safety of Two-Dose Regimens of Peginterferon Alpha-2a Compared with Interferon Alpha-2a in Chronic Hepatitis C: A Multicenter, Randomized Controlled Trial

Paul J. Pockros, Robert L. Carithers, Paul Desmond et al. · The American Journal of Gastroenterology · 2004 · 81 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

Thierry Poynard, Patrick Marcellin, Samuel S. Lee et al. · European Journal of Gastroenterology & Hepatology · 1998 · 46 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

GS-02-Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial

George Ν. Dalekos, Pietro Invernizzi, Frederik Nevens et al. · Journal of Hepatology · 2019 · 20 citations

Medicine, Internal Medicine, Pharmacotherapy +11